Literature DB >> 25738816

Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

Karuna P Karunakaran1, Hong Yu1, Xiaozhou Jiang1, Queenie Chan2, Kyung-Mee Moon2, Leonard J Foster2, Robert C Brunham3.   

Abstract

CD4 T cell immune responses such as interferon-γ and tumor necrosis factor-α secretion are necessary for Chlamydia immunity. We used an immunoproteomic approach in which Chlamydia trachomatis and Chlamydia muridarum-derived peptides presented by MHC class II molecules on the surface of infected dendritic cells (DCs) were identified by tandem mass spectrometry using bone marrow derived DCs (BMDCs) from mice of different MHC background. We first compared the C. muridarum immunoproteome in C3H mice to that previously identified in C57BL/6 mice. Fourteen MHC class II binding peptides from 11 Chlamydia proteins were identified from C3H infected BMDCs. Two C. muridarum proteins overlapped between C3H and C57B/6 mice and both were polymorphic membrane proteins (Pmps) which presented distinct class II binding peptides. Next we studied DCs from C57BL/6 mice infected with the human strain, C. trachomatis serovar D. Sixty MHC class II binding peptides derived from 27 C. trachomatis proteins were identified. Nine proteins were orthologous T cell antigens between C. trachomatis and C. muridarum and 2 of the nine were Pmps which generated MHC class II binding epitopes at distinct sequences within the proteins. As determined by antigen specific splenocyte responses outer membrane proteins PmpF, -G and -H and the major outer membrane protein (MOMP) were antigenic in mice previously infected with C. muridarum or C. trachomatis. Furthermore a recombinant protein vaccine consisting of the four Pmps (PmpEFGH) with MOMP formulated with a Th1 polarizing adjuvant significantly accelerated (p<0.001) clearance in the C57BL/6 mice C. trachomatis transcervical infection model. We conclude that Chlamydia outer membrane proteins are important T cell antigens useful in the development of a C. trachomatis subunit vaccine.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen; Chlamydia; Epitope; Immunoproteomics; MHC; Outer membrane proteins; Peptide; T cell; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 25738816      PMCID: PMC4390527          DOI: 10.1016/j.vaccine.2015.02.055

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

Review 1.  Exploiting dendritic cells to improve vaccine efficacy.

Authors:  Ralph M Steinman; Melissa Pope
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 2.  Contribution of mass spectrometry to contemporary immunology.

Authors:  A de Jong
Journal:  Mass Spectrom Rev       Date:  1998 Sep-Oct       Impact factor: 10.946

3.  NK T cell activation promotes Chlamydia trachomatis infection in vivo.

Authors:  Laura Bilenki; Shuhe Wang; Jie Yang; Yijun Fan; Antony George Joyee; Xi Yang
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 4.  The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.

Authors:  Andrea J Sant; Francisco A Chaves; Scott A Jenks; Katherine A Richards; Paula Menges; J M Weaver; Christopher A Lazarski
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

5.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 6.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.

Authors:  Robert C Brunham; José Rey-Ladino
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

7.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.

Authors:  Y X Zhang; S Stewart; T Joseph; H R Taylor; H D Caldwell
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis.

Authors:  R S Stephens; S Kalman; C Lammel; J Fan; R Marathe; L Aravind; W Mitchell; L Olinger; R L Tatusov; Q Zhao; E V Koonin; R W Davis
Journal:  Science       Date:  1998-10-23       Impact factor: 47.728

9.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

2.  Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.

Authors:  Shradha Wali; Rishein Gupta; Jieh-Juen Yu; Adelphe Mfuh; Xiaoli Gao; M Neal Guentzel; James P Chambers; Sazaly Abu Bakar; Guangming Zhong; Bernard P Arulanandam
Journal:  Metabolomics       Date:  2016-03-08       Impact factor: 4.290

3.  Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.

Authors:  Karuna P Karunakaran; Hong Yu; Xiaozhou Jiang; Queenie W T Chan; Leonard J Foster; Raymond M Johnson; Robert C Brunham
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

Review 5.  Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Expert Rev Vaccines       Date:  2016-03-21       Impact factor: 5.217

6.  Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes.

Authors:  Daniel L Moss; Hee-Won Park; Ramgopal R Mettu; Samuel J Landry
Journal:  J Biol Chem       Date:  2019-01-25       Impact factor: 5.157

7.  Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.

Authors:  Sukumar Pal; Alison Favaroni; Delia F Tifrea; Philipp T Hanisch; Sören E T Luczak; Johannes H Hegemann; Luis M de la Maza
Journal:  Vaccine       Date:  2017-04-03       Impact factor: 3.641

8.  A Nonsurgical Embryo Transfer Technique for Fresh and Cultured Blastocysts in Rats.

Authors:  Barbara J Stone; Kendra H Steele; Hongsheng Men; Sarah J Srodulski; Elizabeth C Bryda; Angelika Fath-Goodin
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-08-12       Impact factor: 1.232

Review 9.  Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.

Authors:  Sam Vasilevsky; Milos Stojanov; Gilbert Greub; David Baud
Journal:  Virulence       Date:  2015-11-18       Impact factor: 5.882

10.  Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

Authors:  Luis M de la Maza; Toni L Darville; Sukumar Pal
Journal:  Expert Rev Vaccines       Date:  2021-04-28       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.